Brad Moss, a partner at Mark Zaid Plc., discusses special counsel Robert Mueller’s accusations against former Trump campaign chairman Paul Manafort for threatening witnesses. Plus, Shubha Ghosh, director the Syracuse University Intellectual Property law Institute, discusses Allergan’s efforts to transfer the patent for the blockbuster dry-eye drug Restasis to a Native American tribe in a case that could forever change how the U.S. government reviews patents.  They speak with Bloomberg’s June Grasso.